Hemolytic Anemia Notes

Hemolytic Anemia

Objectives

  • Define hemolysis and explain the term 'compensated hemolysis.'

  • List hematological and biochemical indicators of red cell hemolysis.

  • Classify the principal causes of red blood cell hemolysis (e.g., extracorpuscular and intracorpuscular) and cite examples from each category.

  • List and briefly discuss laboratory tests used to differentiate between intravascular and extravascular hemolysis.

  • Explain the principles of the osmotic fragility test.

  • Compare the inheritance pattern of hereditary spherocytosis with that of glucose 6 phosphate dehydrogenase deficiency.

  • Explain the difference between alloimmune and autoimmune hemolysis.

The Normal Removal Of The RBCs

  • RBC life span is approximately 120 days.

  • RBC destruction occurs after this mean life span.

  • Removal happens in the extravascular space by the reticuloendothelial system (phagocytic system) in the bone marrow, spleen, and liver.

Hemolysis

  • Hemolysis is the accelerated destruction of red blood cells (RBCs), leading to decreased RBC survival.

  • The bone marrow's response to hemolysis is increased erythropoiesis, reflected by reticulocytosis.

  • Compensated Hemolysis: If the rate of hemolysis is modest and the bone marrow can completely compensate for the decreased RBC life span, the hemoglobin concentration may be normal.

  • Incompletely Compensated Hemolysis: If the bone marrow cannot completely compensate for hemolysis, anemia occurs.

  • A normal hemoglobin value does not necessarily denote the absence of hemolysis.

Hemolysis Classification

Multiple ways to classify hemolysis:

  • Inheritance: Inherited vs. Acquired

  • Site of RBC destruction:

    • Intravascular: inside blood vessels (e.g., Paroxysmal nocturnal hemoglobinuria (PNH))

    • Extravascular: macrophages in the reticuloendothelial system (liver and spleen); more common (e.g., hereditary spherocytosis)

  • Origin of RBC damage:

    • Intrinsic: to RBC, usually inherited (but not always, e.g., PNH)

    • Extrinsic: to RBC, usually acquired (but not always, e.g., congenital Thrombotic Thrombocytopenic Purpura (TTP))

Clinical Manifestations

  • History/Physical:

    • Fatigue

    • Pallor

    • Jaundice

    • Splenomegaly (in some cases)

  • Free hemoglobin scavenges nitric oxide, so chronically this can result in:

    • Esophageal spasm

    • Non-healing skin ulcers

    • Pulmonary hypertension

  • Chronic intravascular hemolysis:

    • Hemosiderinuria

  • Chronic extravascular hemolysis:

    • Pigmented gallstones

Haptoglobin

  • Haptoglobins are proteins in normal plasma which bind hemoglobin if either intravascular or significant extravascular hemolysis is present.

  • The hemoglobin–haptoglobin complex is removed by the RE system, leading to low haptoglobin levels in hemolysis.

Hemolysis Biomarkers

  • Haptoglobin binds with Hb

  • (Haptoglobin + Hb) Complex is removed by the mononuclear phagocytic system

  • This leads to low haptoglobin levels

Indicators of Red Cell Hemolysis

  1. Features of increased red cell breakdown:

    • (a) Serum bilirubin raised, unconjugated and bound to albumin

    • (b) Urine urobilinogen increased

    • (c) Serum haptoglobins absent because the haptoglobins become saturated with hemoglobin, and the complex is removed by RE cells.

  2. Features of increased red cell production:

    • (a) Reticulocytosis

    • (b) Bone marrow erythroid hyperplasia – the normal marrow myeloid : erythroid ratio of 2:1 to 12:1 is reduced to 1:1 or reversed.

  3. Damaged red cells, visualized by:

    • (a) Routine blood film morphology (e.g., microspherocytes, elliptocytes, fragments)

    • (b) Flow cytometry after eosin-maleimide (EMA) staining

    • (c) Specific enzyme, protein, or DNA tests.

Intravascular vs. Extravascular Hemolysis

  • Intravascular hemolysis: erythrocytes are destroyed in the blood vessel itself.

  • Extravascular hemolysis: occurs in the hepatic and splenic macrophages within the reticuloendothelial system.

Intravascular Hemolysis Details

  • Red cell destruction occurs primarily in the vascular space.

  • Damage to the RBC membrane is significant.

  • Can be detected by blood test → Hemoglobinemia.

  • Free hemoglobin in the urine. Hemoglobinuria → Acute renal failure.

  • Hemosiderin → Iron deficiency anemia. The byproduct of hemolysis → free hemoglobin.

Causes of Intravascular Hemolysis

  • Micro-angiopathic hemolytic anemia (MAHA): hemolytic anemia, thrombocytopenia, and microvascular thrombosis.

  • Thrombotic thrombocytopenic purpura (TTP).

  • Shear stress: aortic stenosis, defective prosthetic valve.

  • Acute hemolytic transfusion reactions (e.g., ABO incompatibility).

  • Infections: clostridia sepsis, severe malaria.

  • Paroxysmal cold hemoglobinuria & cold agglutinin disease (cold AIHA).

  • Paroxysmal nocturnal hemoglobinuria (PNH).

Extravascular Hemolysis Details

  • Red cell destruction primarily in the Reticuloendothelial system.

  • Examples:

    • Warm Autoimmune hemolysis

    • Delayed hemolytic transfusion reactions

    • Hemoglobinopathies (sickle cell and thalassemia)

    • Hereditary spherocytosis

AIHA (Autoimmune Hemolytic Anemia)

  • Shortened survival of RBCs due to auto-antibodies.

  • Warm AIHA:

    • Antibodies bind to RBCs optimally at body temperature (37^{\circ}C).

    • Almost always due to IgG.

    • 80-90% of AIHA.

  • Cold AIHA:

    • Antibodies bind to RBCs optimally at temperature < 37^{\circ}C (optimum temperature of 3 to 4^{\circ}C).

    • Almost always due IgM.

    • Cold reacting IgG

    • 10-20% of AIHA.

Alloimmune Hemolytic Anemia

  • Antibodies are directed against transfused RBCs/foreign RBC antigen:

    • Incompatible blood transfusion:

      • Acute hemolytic transfusion reaction.

      • Delayed hemolytic transfusion reaction.

    • Pregnancy.

Laboratory Testing for Hemolytic Anemia

Test

Type

Comment

Direct antiglobulin (DAT)

Autoimmune

Initial test for any type of hemolytic anemia

Enhanced DAT

Acquired

DAT negative but AIHA still suspected

Cold agglutinin titer

Cold agglutinin disease

Donath-Landsteiner

Paroxysmal cold hemoglobinuria

ADAMTS13 level

Thrombotic thrombocytopenic purpura

Serologic complement

Complement-mediated thrombotic Microangiopathy

Genetic complement

Complement-mediated thrombotic Microangiopathy

Flow cytometry

Paroxysmal nocturnal hemoglobinuria

Eosin-5-maleimide (EMA) binding

Hereditary

Hereditary spherocytosis, elliptocytosis (some)

Osmotic fragility

Hereditary

Hereditary spherocytosis

RBC enzyme activity

RBC enzymopathy

Next generation sequencing

All types

For select patients

Labs to Order - Intravascular vs Extravascular Hemolysis

Test

Intravascular Hemolysis

Extravascular Hemolysis

Note

Reticulocytes

Increase

Increase

Both

Unconjugated bilirubin

Increase

Unchanged/mild decrease

Both

LDH

Increase

Unchanged/mild decrease

Both

Peripheral smear

Schistocytes

Spherocytes

Schistocytes (fragments)

Haptoglobin

Decrease

Unchanged/mild decrease

Urine hemosiderin

Positive after ~1 week

Negative

Urine hemoglobin

Positive

Negative

Carboxyhemoglobin

Increase

Negative

Intracorpuscular vs. Extracorpuscular Hemolysis

  • Intracorpuscular Causes:

    • Hereditary:

      • Enzyme defects:

        • G6PD deficiency

        • Pyruvate kinase deficiency

      • Defects in the RBC membrane:

        • Hereditary spherocytosis

        • Hereditary elliptocytosis

      • Hemoglobinopathies:

        • Thalassemia syndrome

        • Hb S, Hb C

    • Acquired:

      • Paroxysmal nocturnal hemoglobinuria

      • Infections from Clostridia and P.falciparum

  • Extracorpuscular Causes:

    • Immune hemolytic anemia

    • Chemicals and toxins

    • Physical agents

    • Infections

    • Hypersplenism

    • Microangiopathic hemolytic anemia

    • Macroangiopathic hemolytic anemia

Intracorpuscular - Intrinsic Defect

  • Membrane defect: Hereditary spherocytosis.

  • Enzyme defect: G6PD deficiency.

  • HB defect: Hemoglobinopathies.

Intracorpuscular vs. Extracorpuscular - Key Points

  • Intrinsic hemolysis most of the time is due to congenital / inherited causes.

  • Inherited TTP→ extrinsic hemolysis.

  • Extrinsic hemolysis most of time is due to acquired causes.

  • PNH (acquired)→ intrinsic hemolysis

RBC Membrane Disorders

  • Include:

    • Hereditary spherocytosis

    • Hereditary elliptocytosis

    • Hereditary pyropoikilocytosis

  • Characterized by:

    • Deficiency or dysfunction of one or more membrane proteins

    • Shortened RBC survival by hemolysis

Hereditary Spherocytosis

  • Epidemiology:

    • Common in Northern Europeans

  • Inheritance pattern:

    • 75% autosomal dominant

    • 25% sporadic

  • Pathophysiology:

    • Aberrant interaction between the skeleton and overlying lipid bilayer

    • “Vertical interactions”

  • Spherocytes

    • Don’t deform easily making it difficult to travel through the splenic vascular walls à further membrane loss

    • sphErocytes = Extravascular hemolysis

    • Causes: defect in RBC membrane:

      • Ankyrin

      • spectrin

      • Band 3 mutation

      • Protein 4.2

Osmotic Fragility Test

  • Osmotic fragility testing: Increasing hypotonic saline solutions

  • Increased RBC lysis compared with normal RBCs

  • Sensitivity enhanced by 24 h incubation at 37^{\circ}C

  • Not specific for HS (spherocytes of any cause will be positive)

Osmotic Fragility Test for HS

  • Osmotic fragility is a test to measure red cell hemolysis

  • Cell resistance to hemolysis when exposed to a series of increasingly dilute saline solution

  • The sooner hemolysis occurs, the greater the osmotic fragility of the cells.

G6PD Deficiency

  • Most frequently encountered abnormality of RBC metabolism

  • Affects >200 million people worldwide

  • Survival advantage with P. Falciparum

  • Pathophysiology:

    • Hemolysis = due to failure to generate adequate NADPH

    • Leads to decreased levels of reduced glutathione

    • RBCs susceptible to oxidation of Hb by oxidant radicals

    • Denatured Hb aggregates form intraerythrocytic Heinz bodies

    • Heinz bodies bind to RBC cytoskeleton leads to reduced cellular deformity

    • Cells with Heinz bodies are trapped in the spleen, cell membrane becomes pitted and is lost, hemolysis

  • Inheritance:

    • Gene for G6PD is on X-chromosome

Hemolysis Triggers in G6PD Deficiency

  • Infections and other acute illnesses (e.g., diabetic ketoacidosis)

  • Drugs:

    • Antimalarials (e.g., primaquine, pamaquine, chloroquine, Fansidar, Maloprim, quinine)

    • Sulphonamides and sulphones (e.g., co-trimoxazole, sulfanilamide, dapsone, sulfasalazine)

    • Other antibacterial agents (e.g., quinolones, nitrofurans, nalidixic acid, chloramphenicol)

    • Analgesics (e.g., aspirin); moderate doses are safe

    • Antihelminths (e.g., β-naphthol, stibophen)

    • Miscellaneous (e.g., vitamin K analogues, rasburicase, glibenclamide, naphthalene (mothballs), probenecid)

  • Fava beans

  • Chemical oxidants

N.B. Many common drugs have been reported to precipitate hemolysis in G6PD deficiency in some patients (e.g., aspirin, quinine, and penicillin), but not at conventional dosage.